relatlimab,nivolumab
bms
['nsclc', 'agent', 'sclc', 'lcsm,(-blcsm)']
#esmo22 exquisite comprehensive overview of future directions in #immunotherapy of advanced #nsclc by natasha leigh: iciagonists/antagonists /combos t-cell engagers/bites tils promoting agents cell vaccines adenosine targeting agents
#some #lcsm 
#MedicalOncologist MSc Transl Res Univ Paris Sud   #LungCancer biology, immunotherapy, clinical trials #LCSM @myESMO faculty #OncoAlert   live to give